Bills › 88th General Assembly
Where it is now
- Done: IntroducedMarch 13, 2019
- Done: SubcommitteeMarch 6, 2019
- Done: House committeeMarch 7, 2019
- Done: Passes the HouseMarch 26, 201996–3
- Done: Senate committeeApril 4, 2019
- Done: Passes the SenateApril 27, 201940–7
- Done: To the GovernorMay 7, 2019
- Stopped: VetoedMay 24, 2019
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to the medical cannabidiol Act (Code chapter 124E). The bill replaces “untreatable pain” with “severe and chronic pain” on the list of debilitating medical conditions for which medical cannabidiol may be recommended by a health care practitioner. The bill adds physician assistants and advanced registered nurse practitioners to the list of health care practitioners who may certify a person to receive a medical cannabidiol registration card.2(6), is allowed to contain. _____ THC to a patient or a patient’s caregiver in a 90-day period.
Read the full explanation
The bill allows the department of public health to lower this limit by rule. The bill allows the department to disclose certain patient information to authorized employees of medical cannabidiol dispensaries to ensure that a person has not purchased THC in excess of this limit. The bill removes the prohibition on certain felons who are patients applying for a medical cannabidiol registration card. The bill allows a medical cannabidiol dispensary to employ a pharmacist or pharmacy technician licensed or registered pursuant to Code chapter 155A. The bill directs the department of public health to adopt rules for the collection and evaluation of data regarding patient demographics, effective treatment options, clinical outcomes, and quality of life outcomes for the purpose of reporting on the benefits, risks, and outcomes encountered by patients with a debilitating medical condition engaged in the use of medical cannabidiol.
Changed since by amendments H-1080, H-1074; see Amendments.
House subcommittee
Named March 6, 2019. On March 6, 2019 it recommended amendment and passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Fiscal note
AI summary This bill changes the Iowa Medical Cannabidiol Program by expanding the list of qualifying medical conditions, allowing more types of health care practitioners to certify patients, and removing certain restrictions on felons and THC levels. The Department of Public Health will see an estimated $70,000 increase in expenditures to add a community health consultant, and they may need to hire additional registration clerks at approximately $47,000 for every 3,000 new applications received. Costs to update the Seed-to-Sale tracking system are expected to be covered by a $350,000 appropriation from the fiscal year 2019 Technology Reinvestment Fund.2
Read the fiscal note
Description
House File 732 amends the Iowa Medical Cannabidiol (mCBD) Program. Changes relevant to the fiscal impact include:
- Revises “untreatable pain” to “severe or chronic pain” on the list of debilitating medical conditions for which mCBD may be used.
- Expands the definition of “health care practitioner” to include physician assistants and advanced registered nurse practitioners and makes conforming program changes.
- Removes restrictions on felons.
- Removes the restriction on mCBD containing more than 3.0% tetrahydrocannabinol (THC).
- Adds a restriction that an mCBD dispensary cannot dispense more than a combined total of 25 grams of THC to a patient or primary caregiver in a 90-day period.
- Requires the Board of Medicine adopt rules to allow the mCBD Advisory Board to grant a waiver for patients to receive more than a combined total of 25 grams of THC in a 90-day period if the health care practitioner determines that a 25-gram supply is inadequate to alleviate the patient’s debilitating medical condition and that the patient’s debilitating medical condition is terminal with less than one year of life expectancy.
- Requires the Department of Public Health (DPH) to collect and evaluate data on patient clinical outcomes and quality of life outcomes for the purpose of reporting on benefits, risks, and outcomes for patients engaged in the use of mCBD.
Background
Sales of mCBD through the Iowa mCBD Program began in December 2018.
Assumptions
- Expanding the list of debilitating medical conditions for which mCBD may be used and allowing for more certifying health care practitioners will increase patient access to mCBD.
- The Seed-to-Sale tracking system will require updates to comply with the new purchasing cap.
- The DPH will require a community health consultant to be added to mCBD Program staff to conduct data collection and reporting on patient outcomes.
- The mCBD Program is a fee-sustaining program.
Fiscal Impact
To the extent that more patients qualify for the Program and more certifying health care practitioners are available to certify conditions, there will be increased applications to the DPH for mCBD registration. If the application volume increases enough, the DPH will need to hire additional registration clerks at approximately $47,000 for every 3,000 applications received in a given year.
The addition of a community health consultant will increase mCBD Program expenditures by an estimated $70,000.
Expenditures required to support the Seed-to-Sale tracking system changes are anticipated to be covered by the FY 2019 Technology Reinvestment Fund appropriation of $350,000.
Sources
- Department of Public Health
- Final Fiscal Note - Medical Cannabidiol · May 24, 2019 · $47,000
- Medical Cannabidiol · March 29, 2019 · $47,000
- Medical Cannabidiol · March 18, 2019 · $47,000
Iowa Code it changes
Lobbying
13 for · 2 against · 21 undecided · Who →
Family tree
Study bill
88th General Assembly